1.
A requesting Member State, third country or territory may receive not more than half of the stocks of an antigen, vaccine or diagnostic reagent available in the Union antigen, vaccine and diagnostic reagent bank.
2.
In addition to the condition laid down in point 1, the following shall be taken into account:
(a)
the time needed for the contracted manufacturer to produce and to replenish the Union antigen, vaccine and diagnostic reagent bank with the equivalent type and quantity of antigen, vaccine or diagnostic reagent; and
(b)
the availability of the antigen, vaccine or diagnostic reagent on the market.